Literature DB >> 34412929

Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma.

S Huang1, H Cai1, F Song1, Y Zhu1, C Hou1, J Hou2.   

Abstract

Occult cervical lymph node metastasis is a significant prognostic factor in patients with early-stage (cT1/2N0) oral squamous cell carcinoma (OSCC). The aim of this study was to investigate the potential value of the tumor-stroma ratio (TSR) as a histological predictor of occult cervical metastasis and survival in early-stage OSCC. This retrospective study included 151 patients who underwent excision of the primary lesion and elective neck dissection from 2013 to 2017. The clinicopathological features of the tumor, risk factors associated with occult neck metastasis, and prognostic factors for overall survival (OS) and disease-free survival (DFS) were studied. A significant correlation of TSR (P = 0.009) was found with occult neck metastasis in the multivariate logistic regression model. Multivariate Cox proportional hazards regression analysis showed that the TSR (P = 0.002) and perineural invasion (P = 0.011) were associated with OS. Occult neck metastasis (P = 0.032) was associated with DFS. These findings indicate that assessment of the TSR might be useful in prognostication for early-stage OSCC patients. Moreover, the TSR is effective in allowing an accurate evaluation of the risk of occult neck metastasis, and this may be easily applicable in the routine pathological diagnosis and clinical decision-making for elective neck dissection.
Copyright © 2021 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lymphatic metastasis; prognosis; squamous cell carcinoma of head and neck; survival; tumor microenvironment

Mesh:

Year:  2021        PMID: 34412929     DOI: 10.1016/j.ijom.2021.06.011

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  2 in total

Review 1.  Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.

Authors:  Byeong-Oh Hwang; Se-Young Park; Eunae Sandra Cho; Xianglan Zhang; Sun Kyoung Lee; Hyung-Joon Ahn; Kyung-Soo Chun; Won-Yoon Chung; Na-Young Song
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

2.  Nodal Disease and Survival in Oral Cancer: Is Occult Metastasis a Burden Factor Compared to Preoperatively Nodal Positive Neck?

Authors:  Selgai Haidari; Katharina Theresa Obermeier; Moritz Kraus; Sven Otto; Florian Andreas Probst; Paris Liokatis
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.